To further explore whether T lymphocytes mediate the anti‐tumor effect of LSS, we continued to examine the changes of tumor T lymphocytes, including CD8+ and CD4+ T lymphocytes, by flow cytometry (Figure 5A). This evidence concerns the gene CD4 and neoplasm.